Egmidio Medina

1.2k citations
10 papers · 173 indexed · h-index 7
Topics
Immunotherapy and Immune Responses (5 papers)Cancer Immunotherapy and Biomarkers (5 papers)Melanoma and MAPK Pathways (5 papers)

In The Last Decade

Egmidio Medina

10 papers receiving 173 citations

Peers

Egmidio Medina
Comparison fields: 5 of 45
  • Oncology 106
  • Immunology 80
  • Molecular Biology 64
  • Cancer Research 24
  • Pulmonary and Respiratory Medicine 22
Replace Anamarija Markota with:
Anamarija Markota Germany
Mélanie Buchi Switzerland
Mark Buckup United States
Bryant Harbourne Canada
Marnix Geukes Foppen Netherlands
Laura Gibson United States
Sanam Peyvandi Switzerland
Madisson Oliwa United States
Samantha B. Kemp United States
Priscilla S.W. Cheng United Kingdom
Egmidio Medina relative to Anamarija Markota Germany Anamarija Markota's profile →
Citations per field
00.5×7.9×
Anamarija Markota · 1×
Citations per year

Countries citing papers authored by Egmidio Medina

Since Specialization
Citations

This map shows the geographic impact of Egmidio Medina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egmidio Medina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egmidio Medina more than expected).

Fields of papers citing papers by Egmidio Medina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egmidio Medina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egmidio Medina. The network helps show where Egmidio Medina may publish in the future.

Co-authorship network of co-authors of Egmidio Medina

This figure shows the co-authorship network connecting the top 25 collaborators of Egmidio Medina. A scholar is included among the top collaborators of Egmidio Medina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Egmidio Medina. Egmidio Medina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 4
2 14
3 22
4 10
5 50
6 8
7 5
8 16
9 40
10 4

About Egmidio Medina

Egmidio Medina is a scholar working on Immunology, Oncology and Genetics, having authored 10 papers that have together received 173 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Melanoma and MAPK Pathways (5 papers). The work is most often cited by research in Oncology (106 citations), Immunology (80 citations) and Cancer Research (24 citations). Egmidio Medina has collaborated with scholars based in United States, United Kingdom and South Africa. Frequent co-authors include Antoni Ribas, Katie M. Campbell, Gabriel Abril-Rodríguez, Davis Y. Torrejon, Ameya S. Champhekar, F. Stephen Hodi, Katherine M. Sheu, Lisa Salvador, Daniel J. Tenney and Anusha Kalbasi. Their work appears in journals such as Journal of Clinical Investigation, Cancer Cell and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026